OBJECTIVES: Drugs used for the treatment of rheumatoid arthritis (RA) have the potential to affect cardiovascular risk factors. There is concern that corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors could affect cardiovascular risk adversely, while drugs such as the antimalarial, hydroxychloroquine, may have beneficial effects. However, there is limited information about cardiovascular risk factors…
Archives of Drug Information Template
Write in a clean editor, then format for Archives of Drug Information in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Archives of Drug Information format
Archives of Drug Information is a peer-reviewed journal published by Wiley, covering Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Pharmacological Effects and Toxicity Studies.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Archives of Drug Information 12 (3): 45–58.
Formats any DOI in Archives of Drug Information style. No sign-up. |
| Publishes research in | Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Pharmacological Effects and Toxicity Studies HIV/AIDS drug development and treatment Pain Management and Opioid Use |
| ISSN | 1753-5174 |
| h-index | 13 |
| i10-index | 22 |
| Total citations | 582 |
| Top institutions publishing here | Vanderbilt University |
| Journal website | www.blackwellpublishing.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Archives of Drug Information per year
Citation impact of Archives of Drug Information by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Archives of Drug Information
OBJECTIVES: Rifampin is a potent inducer of the cytochrome P450 3A4 isoenzyme (CYP3A4) that metabolizes most protease inhibitor (PI) antiretrovirals. This study was designed to evaluate the steady-state pharmacokinetics and tolerability of the coadministration of the PIs saquinavir and ritonavir (a CYP3A4 inhibitor used as a pharmacoenhancer of other PIs) and rifampin when coadministered in…
AIM: To investigate the influence of probiotic pre-treatment on the permeation of the antidiabetic drug gliclazide in healthy and diabetic rats. METHODS: Wistar rats (age 2-3 months, weight 350 +/- 50 g) were randomly allocated into one of 4 groups (N = 16 each group): healthy control, healthy probiotic, diabetic control, and diabetic probiotic. Probiotics…
INTRODUCTION: Studies using MDCKII and LLC-PK1 cells transfected with MDR1 cDNA indicate that ciprofloxacin is not a substrate of P-glycoprotein. However, our data has shown that transport studies done using different P-gp overexpressing cell lines (MDCKI-MDR1, MDCKII-MDR1 and L-MDR1), could lead to contradictory conclusion on whether a compound is a substrate of P-gp. The aim…
OBJECTIVES: The penetration of hydrocortisone (HC) from six topical over-the-counter products along with one prescription cream through cultured normal human-derived epidermal keratinocytes (Epiderm™), mouse skin and synthetic nylon membrane was performed as well as the effect hydrating the skin by pre-washing was explored using the Upright Franz Cell. METHOD AND RESULTS: Permeation of HC through…